当前位置:首页 - 行情中心 - 永顺生物(920729) - 财务分析 - 现金流量表

永顺生物

(920729)

  

流通市值:4.77亿  总市值:16.84亿
流通股本:7750.70万   总股本:2.73亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金140,068,154.892,045,821.0346,525,651.28273,203,456.01
  收到其他与经营活动有关的现金7,722,877.196,527,042.054,201,816.484,013,556.01
  经营活动现金流入小计147,791,031.9998,572,863.0850,727,467.76277,217,012.02
  购买商品、接受劳务支付的现金47,227,467.6532,640,247.6118,481,732.0362,754,107.73
  支付给职工以及为职工支付的现金40,887,553.3429,389,952.4917,108,843.7255,144,709.95
  支付的各项税费11,901,917.499,152,2303,984,887.611,499,951.03
  支付其他与经营活动有关的现金32,224,018.5524,482,566.7710,862,413.8347,785,547.9
  经营活动现金流出小计132,240,957.0395,664,996.8750,437,877.18177,184,316.61
  经营活动产生的现金流量净额15,550,074.962,907,866.21289,590.58100,032,695.41
二、投资活动产生的现金流量:
  收回投资收到的现金551,765,176.27392,348,493.99186,166,395.15361,108,866.91
  取得投资收益收到的现金10,915.565,858.95--
  处置固定资产、无形资产和其他长期资产收回的现金净额48,00048,000-1,600
  投资活动现金流入小计551,824,091.83392,402,352.94186,166,395.15361,110,466.91
  购建固定资产、无形资产和其他长期资产支付的现金3,598,9261,580,102238,2006,980,695.5
  投资支付的现金486,970,000338,100,000162,000,000450,559,800.4
  投资活动现金流出小计490,568,926339,680,102162,238,200457,540,495.9
  投资活动产生的现金流量净额61,255,165.8352,722,250.9423,928,195.15-96,430,028.99
三、筹资活动产生的现金流量:
  取得借款收到的现金495,984.32495,984.32495,984.321,331,613.62
  收到其他与筹资活动有关的现金---14,182,800
  筹资活动现金流入小计495,984.32495,984.32495,984.3215,514,413.62
  分配股利、利润或偿付利息支付的现金35,535,50035,535,500-35,535,500
  支付其他与筹资活动有关的现金666,587.95315,390.36157,695.18630,924.8
  筹资活动现金流出小计36,202,087.9535,850,890.36157,695.1836,166,424.8
  筹资活动产生的现金流量净额-35,706,103.63-35,354,906.04338,289.14-20,652,011.18
四、汇率变动对现金及现金等价物的影响-1,199,424.53-779,574.04-324,759.84-153,330.43
五、现金及现金等价物净增加额39,899,712.6319,495,637.0724,231,315.03-17,202,675.19
  加:期初现金及现金等价物余额19,237,898.9919,237,898.9919,237,898.9936,440,574.18
  期末现金及现金等价物余额59,137,611.6238,733,536.0643,469,214.0219,237,898.99
补充资料:
  净利润-6,414,601.68-41,257,977.62
  资产减值准备-3,220,552.27-1,428,271.68
  固定资产和投资性房地产折旧-14,139,937.15-29,847,539.16
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-14,139,937.15-29,847,539.16
  无形资产摊销-1,860,343.79-3,417,950.33
  长期待摊费用摊销-409,728.96-255,874.63
  处置固定资产、无形资产和其他长期资产的损失--47,058.82--
  固定资产报废损失-6,009.35-25,482.94
  公允价值变动损失--63,829.96--196,719.6
  财务费用-870,151.37-269,039.23
  投资损失--5,308,817.76--12,251,556.96
  递延所得税-355,030.24-487,459.63
  其中:递延所得税资产减少---339,323.34
    递延所得税负债增加-355,030.24-148,136.29
  存货的减少--5,181,996.85--6,239,013.96
  经营性应收项目的减少-409,507.73-32,521,505.62
  经营性应付项目的增加--16,972,710.92-1,193,449.95
  其他-1,674,798.25-8,694,693.54
  现金的期末余额-38,733,536.06-19,237,898.99
  减:现金的期初余额-19,237,898.99-36,440,574.18
  现金及现金等价物的净增加额-19,495,637.07--17,202,675.19
公告日期2026-10-282026-08-242026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑